Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Patrick Johnston

Concepts (717)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
57
2025
189
11.430
 Why?
Lymphoma, Non-Hodgkin
37
2025
123
6.900
 Why?
Hematopoietic Stem Cell Transplantation
34
2025
670
4.980
 Why?
Visual Perception
7
2025
177
3.260
 Why?
Transplantation, Autologous
33
2025
280
3.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
46
2026
1786
3.080
 Why?
Lymphoma
18
2024
228
2.750
 Why?
Hodgkin Disease
18
2026
157
2.460
 Why?
Salvage Therapy
13
2024
154
2.380
 Why?
Immunotherapy, Adoptive
22
2025
359
2.300
 Why?
Antigens, CD19
12
2024
137
2.170
 Why?
Neoplasm Recurrence, Local
24
2025
1067
2.100
 Why?
Lymphoma, B-Cell
15
2025
131
2.090
 Why?
Central Nervous System Neoplasms
10
2025
168
1.980
 Why?
Reaction Time
6
2025
430
1.880
 Why?
Visual Cortex
2
2025
76
1.670
 Why?
Rituximab
28
2025
205
1.470
 Why?
Lymphoma, Follicular
13
2025
53
1.450
 Why?
Biological Products
9
2023
239
1.210
 Why?
Aged
118
2025
24666
1.150
 Why?
Everolimus
11
2018
110
1.080
 Why?
Middle Aged
128
2026
34487
1.040
 Why?
Adult
124
2026
39134
1.040
 Why?
Humans
229
2026
140898
1.000
 Why?
Granulocyte Colony-Stimulating Factor
5
2021
89
0.950
 Why?
Male
146
2025
69893
0.930
 Why?
Aged, 80 and over
60
2025
7899
0.930
 Why?
Retrospective Studies
60
2025
16315
0.930
 Why?
Evoked Potentials
4
2025
131
0.900
 Why?
Young Adult
53
2026
13646
0.890
 Why?
Female
140
2025
75540
0.860
 Why?
Disease-Free Survival
29
2023
713
0.830
 Why?
Prognosis
43
2025
4060
0.770
 Why?
Monocytes
9
2019
578
0.750
 Why?
Antineoplastic Agents
18
2021
2156
0.740
 Why?
Photic Stimulation
5
2025
256
0.730
 Why?
Attention
2
2025
454
0.720
 Why?
Waldenstrom Macroglobulinemia
5
2023
19
0.720
 Why?
Fluorodeoxyglucose F18
8
2024
147
0.720
 Why?
Peripheral Blood Stem Cell Transplantation
10
2015
33
0.710
 Why?
Lymphocyte Count
17
2022
167
0.710
 Why?
Sirolimus
6
2015
276
0.700
 Why?
Recurrence
17
2024
1104
0.690
 Why?
Lymphocytes
8
2019
394
0.690
 Why?
Lymphoma, Mantle-Cell
6
2022
29
0.680
 Why?
Brain Mapping
6
2022
527
0.680
 Why?
Electroencephalography
6
2025
518
0.680
 Why?
Cyclophosphamide
15
2025
256
0.680
 Why?
Radiopharmaceuticals
6
2021
188
0.650
 Why?
Multiple Myeloma
7
2023
282
0.620
 Why?
Neurotoxicity Syndromes
4
2023
39
0.610
 Why?
Treatment Outcome
40
2025
11125
0.590
 Why?
Doxorubicin
13
2025
358
0.590
 Why?
Vincristine
11
2025
131
0.580
 Why?
Retinal Neoplasms
5
2018
36
0.580
 Why?
Retinal Detachment
6
2009
74
0.570
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
5
2021
75
0.560
 Why?
Survival Rate
21
2021
1962
0.550
 Why?
Spatial Processing
1
2017
1
0.530
 Why?
Neoplasms, Second Primary
2
2017
99
0.520
 Why?
Positron-Emission Tomography
7
2024
309
0.510
 Why?
Time Perception
1
2017
33
0.510
 Why?
Prednisone
10
2025
228
0.510
 Why?
Antibodies, Monoclonal, Murine-Derived
11
2017
96
0.490
 Why?
Combined Modality Therapy
9
2024
1240
0.490
 Why?
Brain
7
2021
2852
0.490
 Why?
Methotrexate
4
2025
255
0.470
 Why?
Transplantation Conditioning
10
2015
184
0.470
 Why?
Drug Resistance, Neoplasm
8
2025
832
0.460
 Why?
Cell Transformation, Neoplastic
5
2019
332
0.460
 Why?
Face
1
2016
175
0.450
 Why?
Antibodies, Monoclonal
9
2017
1471
0.450
 Why?
Stem Cell Transplantation
7
2021
187
0.450
 Why?
Vitreous Body
7
2018
122
0.440
 Why?
Piperidines
5
2022
217
0.430
 Why?
Survival Analysis
19
2021
1320
0.430
 Why?
Antineoplastic Agents, Immunological
3
2021
193
0.420
 Why?
Autografts
6
2022
50
0.420
 Why?
Follow-Up Studies
24
2025
5194
0.420
 Why?
Positron Emission Tomography Computed Tomography
4
2023
110
0.400
 Why?
Synovial Cyst
1
2013
5
0.400
 Why?
Amyloidosis
4
2018
49
0.380
 Why?
Pyrimidines
6
2025
508
0.380
 Why?
Pyrazoles
5
2022
480
0.380
 Why?
Antigens, CD20
5
2017
35
0.370
 Why?
Wrist
1
2013
58
0.370
 Why?
Lymphoma, B-Cell, Marginal Zone
3
2022
17
0.370
 Why?
Fingers
1
2013
106
0.370
 Why?
Radioimmunotherapy
4
2017
21
0.360
 Why?
Lymphoma, T-Cell
3
2015
29
0.340
 Why?
Eye Neoplasms
5
2014
28
0.330
 Why?
Protein-Tyrosine Kinases
3
2009
430
0.320
 Why?
Orthopedic Procedures
1
2013
229
0.320
 Why?
Lasers, Solid-State
1
2009
23
0.300
 Why?
Neoplasm Proteins
4
2019
433
0.300
 Why?
Burkitt Lymphoma
3
2022
63
0.290
 Why?
Neoplasm Staging
12
2020
1396
0.290
 Why?
Cataract Extraction
2
2009
106
0.290
 Why?
Adolescent
32
2026
22027
0.290
 Why?
Molecular Targeted Therapy
2
2010
418
0.290
 Why?
Kaplan-Meier Estimate
12
2018
907
0.280
 Why?
Risk Factors
23
2022
10430
0.280
 Why?
Thalidomide
3
2018
44
0.270
 Why?
Mechanistic Target of Rapamycin Complex 1
4
2018
131
0.270
 Why?
Killer Cells, Natural
4
2023
467
0.260
 Why?
Hematopoietic Stem Cell Mobilization
3
2012
27
0.260
 Why?
Dexamethasone
6
2022
379
0.260
 Why?
Pattern Recognition, Visual
2
2025
102
0.260
 Why?
Lymphoma, T-Cell, Peripheral
2
2024
20
0.250
 Why?
TOR Serine-Threonine Kinases
4
2017
428
0.250
 Why?
Transfusion Reaction
1
2006
62
0.250
 Why?
Chemoradiotherapy
2
2021
232
0.240
 Why?
Fracture Fixation
1
2006
84
0.240
 Why?
RNA, Small Interfering
2
2007
624
0.240
 Why?
Hip Fractures
1
2006
86
0.230
 Why?
Peripheral Nervous System Neoplasms
1
2025
19
0.230
 Why?
Adaptation, Physiological
2
2022
562
0.230
 Why?
Event-Related Potentials, P300
1
2025
15
0.230
 Why?
Central Nervous System
3
2023
264
0.230
 Why?
Eye Injuries
3
1991
53
0.230
 Why?
Medical Oncology
2
2026
316
0.220
 Why?
B-Lymphocytes
6
2023
857
0.220
 Why?
Thrombocytopenia
3
2022
207
0.220
 Why?
Acute Kidney Injury
2
2022
820
0.220
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2024
31
0.220
 Why?
Skin Neoplasms
2
2022
853
0.220
 Why?
Conditioning, Classical
2
2022
106
0.210
 Why?
Perioperative Care
1
2006
226
0.210
 Why?
Hepatitis A
1
2024
26
0.210
 Why?
Mediastinal Neoplasms
1
2024
51
0.210
 Why?
Cancer Vaccines
1
2025
166
0.210
 Why?
Fear
2
2022
344
0.210
 Why?
Aqueous Humor
2
2014
38
0.210
 Why?
Multiprotein Complexes
3
2017
171
0.210
 Why?
Incidence
9
2024
2782
0.210
 Why?
Orientation
1
2023
52
0.200
 Why?
Immunoglobulin kappa-Chains
2
2014
24
0.200
 Why?
Hydroxamic Acids
2
2014
94
0.200
 Why?
Predictive Value of Tests
11
2018
2062
0.200
 Why?
Extinction, Psychological
2
2022
88
0.200
 Why?
Standard of Care
4
2025
77
0.200
 Why?
Prospective Studies
15
2025
7749
0.200
 Why?
Immunologic Factors
3
2014
249
0.190
 Why?
Cerebellum
2
2017
218
0.190
 Why?
Cell- and Tissue-Based Therapy
4
2024
85
0.190
 Why?
Venous Thromboembolism
2
2022
336
0.190
 Why?
Facial Expression
1
2023
77
0.190
 Why?
Magnetic Resonance Imaging
9
2024
3724
0.190
 Why?
Vitamin D Deficiency
2
2017
187
0.190
 Why?
Tomography, X-Ray Computed
4
2016
2760
0.190
 Why?
Yttrium Radioisotopes
4
2017
63
0.180
 Why?
Electromyography
1
2024
411
0.180
 Why?
Carmustine
2
2020
51
0.180
 Why?
Brain Diseases
1
2023
149
0.180
 Why?
Transcription Factors
1
2010
1703
0.180
 Why?
Myeloid Differentiation Factor 88
2
2019
105
0.180
 Why?
Bortezomib
4
2018
53
0.180
 Why?
Immunoglobulin Light Chains
3
2013
51
0.180
 Why?
Status Epilepticus
1
2022
54
0.180
 Why?
Facial Recognition
1
2022
35
0.180
 Why?
Magnesium Deficiency
1
2021
2
0.180
 Why?
Measles virus
3
2010
20
0.180
 Why?
Central Nervous System Diseases
1
2022
73
0.170
 Why?
Hypoalbuminemia
1
2021
30
0.170
 Why?
Immunoconjugates
1
2022
125
0.170
 Why?
Fluorine Radioisotopes
1
2021
13
0.170
 Why?
Space Perception
1
2021
86
0.170
 Why?
Bacterial Infections
1
2023
245
0.170
 Why?
Vision, Ocular
1
2020
45
0.170
 Why?
Magnesium
1
2021
158
0.170
 Why?
Autism Spectrum Disorder
2
2017
418
0.170
 Why?
Schizophrenia
2
2017
441
0.160
 Why?
Autoimmunity
2
2018
906
0.160
 Why?
Antigens, CD34
2
2010
89
0.160
 Why?
Testis
1
2021
158
0.160
 Why?
Cytokines
4
2021
2092
0.160
 Why?
Medication Systems
1
2000
4
0.160
 Why?
Molecular Epidemiology
2
2017
72
0.160
 Why?
Filgrastim
2
2017
12
0.160
 Why?
Heterocyclic Compounds
2
2012
23
0.160
 Why?
Retinal Perforations
3
1996
19
0.160
 Why?
Lymphopenia
2
2010
67
0.160
 Why?
Automation
1
2000
100
0.150
 Why?
Leukemia, B-Cell
1
2019
13
0.150
 Why?
Melphalan
4
2017
40
0.150
 Why?
Leg
1
2021
236
0.150
 Why?
Drug Administration Schedule
8
2017
766
0.150
 Why?
Nursing Staff
1
2000
45
0.150
 Why?
Cost-Benefit Analysis
1
2022
609
0.150
 Why?
Protein Kinase Inhibitors
4
2019
917
0.150
 Why?
Proportional Hazards Models
7
2023
1261
0.150
 Why?
Recombinant Proteins
3
2017
1361
0.150
 Why?
Enterocolitis, Necrotizing
2
2010
40
0.150
 Why?
Cohort Studies
12
2022
5789
0.150
 Why?
Cues
1
2021
323
0.150
 Why?
Infusions, Parenteral
1
2018
43
0.150
 Why?
Time Factors
12
2019
6944
0.150
 Why?
Mental Recall
1
2020
210
0.140
 Why?
Leukocyte Count
3
2014
328
0.140
 Why?
Vidarabine
4
2017
35
0.140
 Why?
Janus Kinase 1
1
2018
26
0.140
 Why?
Myeloid-Derived Suppressor Cells
1
2019
73
0.140
 Why?
Autistic Disorder
2
2011
210
0.140
 Why?
Drug Approval
2
2010
87
0.140
 Why?
Leukapheresis
2
2016
26
0.140
 Why?
Mutation, Missense
1
2019
340
0.140
 Why?
Thrombosis
1
2022
398
0.140
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2018
97
0.140
 Why?
Northern Ireland
5
2009
12
0.140
 Why?
Postoperative Complications
2
2006
2813
0.140
 Why?
Contingent Negative Variation
1
2017
9
0.130
 Why?
Immunoglobulin lambda-Chains
2
2014
9
0.130
 Why?
Immunotherapy
2
2019
643
0.130
 Why?
Waste Disposal, Fluid
1
2017
51
0.130
 Why?
Delay Discounting
1
2017
29
0.130
 Why?
Lipopolysaccharide Receptors
1
2017
91
0.130
 Why?
Visual Fields
2
2017
115
0.130
 Why?
Evoked Potentials, Visual
1
2017
40
0.130
 Why?
Fluorouracil
2
2016
206
0.130
 Why?
Immunophenotyping
2
2015
327
0.130
 Why?
Child
15
2024
22313
0.130
 Why?
Maximum Tolerated Dose
4
2019
204
0.130
 Why?
Tarsal Coalition
1
2016
1
0.120
 Why?
Visual Acuity
4
1996
447
0.120
 Why?
Subtalar Joint
1
2016
5
0.120
 Why?
Magnetoencephalography
1
2017
157
0.120
 Why?
Evoked Potentials, Auditory
1
2017
179
0.120
 Why?
Glycine
1
2017
185
0.120
 Why?
Time-to-Treatment
1
2018
223
0.120
 Why?
Case-Control Studies
6
2021
3578
0.120
 Why?
Biomarkers
6
2023
4175
0.120
 Why?
Mental Processes
1
2015
35
0.120
 Why?
Body Fluids
1
1996
70
0.120
 Why?
Uveitis
2
2014
148
0.120
 Why?
Dendritic Cells
1
2019
502
0.120
 Why?
Odds Ratio
4
2018
1054
0.120
 Why?
Myelodysplastic Syndromes
1
2017
142
0.120
 Why?
Antipsychotic Agents
1
2017
208
0.110
 Why?
Outpatients
1
2018
418
0.110
 Why?
United States
6
2025
15195
0.110
 Why?
Hemangioma, Capillary
1
1995
14
0.110
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
250
0.110
 Why?
Lymphoma, Large-Cell, Immunoblastic
1
2014
1
0.110
 Why?
Comprehension
1
2017
182
0.110
 Why?
Psychotic Disorders
1
2017
177
0.110
 Why?
Folic Acid
1
2016
198
0.110
 Why?
Environmental Monitoring
1
2017
369
0.110
 Why?
Boronic Acids
2
2014
35
0.110
 Why?
Polyethylene Glycols
2
2017
639
0.110
 Why?
Obsessive-Compulsive Disorder
1
2015
55
0.110
 Why?
Interleukin-10
2
2013
306
0.110
 Why?
Translocation, Genetic
2
2022
109
0.110
 Why?
Task Performance and Analysis
1
2015
196
0.110
 Why?
Optic Disk
1
1995
52
0.110
 Why?
Biomarkers, Tumor
4
2013
1243
0.110
 Why?
Neoplasms
2
2022
2718
0.110
 Why?
Water Pollutants, Chemical
1
2017
225
0.110
 Why?
Prefrontal Cortex
1
2017
316
0.110
 Why?
Pyrazines
2
2014
88
0.100
 Why?
Feasibility Studies
2
2016
1022
0.100
 Why?
Myeloid Cells
1
2015
149
0.100
 Why?
Autoimmune Diseases
2
2018
465
0.100
 Why?
Indoles
2
2014
475
0.100
 Why?
Polyneuropathies
1
2013
57
0.100
 Why?
Intestinal Neoplasms
1
2013
31
0.100
 Why?
Intestinal Perforation
1
2013
45
0.100
 Why?
Tachycardia, Supraventricular
1
2013
43
0.100
 Why?
Oligodeoxyribonucleotides
1
2013
143
0.100
 Why?
Retinal Neovascularization
1
1993
28
0.100
 Why?
Quality Assurance, Health Care
2
2008
318
0.100
 Why?
Remission Induction
4
2017
309
0.100
 Why?
POEMS Syndrome
1
2012
2
0.090
 Why?
Peripheral Nerves
1
2013
71
0.090
 Why?
T-Lymphocytes
3
2018
2003
0.090
 Why?
Anti-Bacterial Agents
2
2023
1856
0.090
 Why?
Programmed Cell Death 1 Receptor
1
2014
260
0.090
 Why?
Scleral Diseases
1
1992
2
0.090
 Why?
Hematologic Neoplasms
2
2013
159
0.090
 Why?
Disease Progression
6
2021
2791
0.090
 Why?
Soft Tissue Neoplasms
1
2013
116
0.090
 Why?
Corneal Diseases
1
1992
44
0.090
 Why?
Carbonated Beverages
1
1991
16
0.090
 Why?
Epidermolysis Bullosa Dystrophica
1
1992
42
0.090
 Why?
Attitude of Health Personnel
1
2000
1175
0.090
 Why?
Cell Proliferation
3
2015
2497
0.090
 Why?
Stomach Neoplasms
1
2013
118
0.090
 Why?
Gene Expression Profiling
2
2011
1761
0.090
 Why?
Blast Injuries
1
1991
58
0.080
 Why?
Oncolytic Virotherapy
1
2010
14
0.080
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2022
236
0.080
 Why?
Oncolytic Viruses
1
2010
8
0.080
 Why?
Samarium
1
2010
1
0.080
 Why?
Gene Targeting
1
2010
83
0.080
 Why?
Myeloablative Agonists
1
2010
23
0.080
 Why?
Radioisotopes
1
2010
36
0.080
 Why?
Arrhythmias, Cardiac
1
2013
337
0.080
 Why?
Cornea
1
1992
154
0.080
 Why?
Gray Matter
1
2011
86
0.080
 Why?
X-Ray Intensifying Screens
1
2010
3
0.080
 Why?
Miosis
1
1990
4
0.080
 Why?
Self Report
1
2015
858
0.080
 Why?
Short Bowel Syndrome
1
2010
27
0.080
 Why?
Leukemia, Myeloid, Acute
1
2017
652
0.080
 Why?
Immunosuppressive Agents
1
2015
854
0.080
 Why?
Surveys and Questionnaires
3
2022
5931
0.080
 Why?
Holidays
1
2009
8
0.080
 Why?
Child Development Disorders, Pervasive
1
2010
62
0.080
 Why?
Indomethacin
1
1990
87
0.080
 Why?
Gene Expression Regulation, Neoplastic
2
2014
1430
0.080
 Why?
Radiometry
1
2010
54
0.080
 Why?
Oxazines
1
2009
32
0.080
 Why?
Minnesota
4
2013
168
0.080
 Why?
Iris Diseases
1
1989
8
0.080
 Why?
Electronics
1
2010
72
0.080
 Why?
Interleukin-15
1
2010
100
0.080
 Why?
Subtraction Technique
1
2009
25
0.080
 Why?
Uveal Neoplasms
1
1989
14
0.080
 Why?
Pain Threshold
1
2009
73
0.080
 Why?
Organophosphorus Compounds
1
2010
82
0.080
 Why?
Severity of Illness Index
4
2015
2898
0.080
 Why?
Organometallic Compounds
1
2010
113
0.080
 Why?
Quinolones
1
2011
173
0.070
 Why?
Lenses, Intraocular
1
1989
45
0.070
 Why?
Fatigue
2
2024
338
0.070
 Why?
Atrial Fibrillation
1
2013
384
0.070
 Why?
Hospitalization
1
2018
2261
0.070
 Why?
Double-Blind Method
3
2019
1978
0.070
 Why?
Radiation Dosage
1
2010
189
0.070
 Why?
Neurons
2
2009
1615
0.070
 Why?
Chromosomes, Human, Pair 6
1
2008
47
0.070
 Why?
Multivariate Analysis
5
2012
1496
0.070
 Why?
Marijuana Abuse
1
2011
230
0.070
 Why?
Treatment Failure
2
2024
353
0.070
 Why?
Amygdala
1
2009
192
0.070
 Why?
Gases
1
1988
50
0.070
 Why?
Fluorescein Angiography
3
1996
175
0.070
 Why?
Vancomycin Resistance
1
2007
16
0.070
 Why?
Obesity
1
2021
3000
0.070
 Why?
Ambulatory Surgical Procedures
1
2008
75
0.070
 Why?
Ophthalmoplegia
1
1987
13
0.070
 Why?
Enterococcus
1
2007
21
0.070
 Why?
Down-Regulation
2
2007
638
0.070
 Why?
Germinal Center
1
2008
66
0.070
 Why?
Child, Preschool
5
2024
11462
0.070
 Why?
Torticollis
1
1987
16
0.070
 Why?
Cytarabine
3
2017
64
0.070
 Why?
Rhinoplasty
1
2008
31
0.070
 Why?
Chromosomes, Human, Pair 2
1
2007
28
0.070
 Why?
Chromosomes, Human, Pair 5
1
2007
29
0.070
 Why?
Models, Neurological
1
2009
248
0.070
 Why?
Carrier State
1
2007
71
0.070
 Why?
Logistic Models
4
2018
2088
0.070
 Why?
Infant, Premature, Diseases
1
2008
107
0.070
 Why?
Proto-Oncogene Proteins c-bcl-6
2
2022
10
0.070
 Why?
Vitamin D
1
2010
392
0.060
 Why?
Temporal Lobe
2
2022
104
0.060
 Why?
Emotions
2
2023
575
0.060
 Why?
Ki-1 Antigen
1
2006
7
0.060
 Why?
Immunohistochemistry
5
2012
1726
0.060
 Why?
Radiotherapy Dosage
2
2021
280
0.060
 Why?
Intracellular Signaling Peptides and Proteins
1
2009
466
0.060
 Why?
Flow Cytometry
4
2015
1195
0.060
 Why?
Prosthesis Implantation
1
2008
156
0.060
 Why?
Proto-Oncogene Proteins c-jun
1
2006
56
0.060
 Why?
Quality of Life
3
2023
3005
0.060
 Why?
Seat Belts
1
1986
20
0.060
 Why?
Eye
1
2007
113
0.060
 Why?
Behavior, Animal
1
2009
515
0.060
 Why?
Reproducibility of Results
4
2015
3336
0.060
 Why?
ROC Curve
2
2023
589
0.060
 Why?
Cerebral Cortex
1
2009
457
0.060
 Why?
Lens, Crystalline
1
1987
133
0.060
 Why?
Hematopoietic Stem Cells
2
2010
411
0.060
 Why?
Anemia
2
2018
176
0.060
 Why?
Lymphocyte Depletion
1
2006
136
0.060
 Why?
Pyridines
1
2009
553
0.060
 Why?
Signal Transduction
2
2010
5148
0.060
 Why?
Risk Assessment
4
2018
3484
0.060
 Why?
Isoquinolines
1
2025
43
0.060
 Why?
Retreatment
2
2017
73
0.060
 Why?
Cross Infection
1
2007
253
0.060
 Why?
Amyloid
1
2006
97
0.060
 Why?
Pregnanolone
1
2005
41
0.060
 Why?
Melanoma
2
1989
792
0.060
 Why?
Neoplasm Grading
2
2018
309
0.060
 Why?
Cognition
2
2024
1220
0.060
 Why?
Induction Chemotherapy
1
2025
80
0.060
 Why?
Cisplatin
2
2022
326
0.050
 Why?
Algorithms
1
2012
1763
0.050
 Why?
Thiophenes
1
2025
124
0.050
 Why?
Vitrectomy
2
2013
78
0.050
 Why?
Aminopterin
1
2024
3
0.050
 Why?
Glaucoma
1
1987
241
0.050
 Why?
Regression Analysis
1
2006
1015
0.050
 Why?
Proteins
1
2010
1013
0.050
 Why?
Psychiatric Status Rating Scales
2
2017
552
0.050
 Why?
Biopsy
2
2019
1069
0.050
 Why?
Apoptosis
2
2015
2571
0.050
 Why?
Area Under Curve
2
2017
323
0.050
 Why?
Immunoglobulins, Intravenous
1
2024
129
0.050
 Why?
Anger
1
2023
62
0.050
 Why?
HLA-DR Antigens
1
2023
227
0.050
 Why?
Lactate Dehydrogenases
1
2022
6
0.050
 Why?
Risk
3
2010
903
0.050
 Why?
Statistics, Nonparametric
2
2017
432
0.050
 Why?
Thymidylate Synthase
1
2002
12
0.050
 Why?
Syndrome
1
2023
377
0.050
 Why?
Cell Line, Tumor
2
2007
3487
0.050
 Why?
Creatine Kinase
1
2022
76
0.050
 Why?
Patient Selection
1
2006
684
0.050
 Why?
Agraphia
1
2021
1
0.050
 Why?
Body Weight
2
2021
992
0.050
 Why?
Ki-67 Antigen
1
2002
111
0.050
 Why?
Gene Expression Regulation
1
2011
2604
0.040
 Why?
Hematologic Diseases
2
2014
66
0.040
 Why?
L-Lactate Dehydrogenase
2
2013
125
0.040
 Why?
Pain
3
2014
776
0.040
 Why?
Wounds and Injuries
1
2009
896
0.040
 Why?
Aphasia
1
2021
23
0.040
 Why?
Confusion
1
2021
31
0.040
 Why?
Sensitivity and Specificity
3
2012
1968
0.040
 Why?
Clinical Trials as Topic
1
2006
1031
0.040
 Why?
Uric Acid
1
2022
164
0.040
 Why?
Cell Cycle Proteins
1
2005
632
0.040
 Why?
DNA-Binding Proteins
1
2008
1478
0.040
 Why?
Stem Cells
1
2005
603
0.040
 Why?
Proto-Oncogene Proteins c-myc
1
2022
163
0.040
 Why?
Glass
2
2009
46
0.040
 Why?
Galvanic Skin Response
1
2020
25
0.040
 Why?
Radiotherapy
1
2021
202
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2021
308
0.040
 Why?
Electroshock
1
2020
142
0.040
 Why?
Serum Albumin
1
2021
152
0.040
 Why?
Creatinine
1
2022
490
0.040
 Why?
Manitoba
1
2000
4
0.040
 Why?
Disease Management
1
2024
628
0.040
 Why?
Benzylamines
2
2012
44
0.040
 Why?
Disease Susceptibility
1
2022
352
0.040
 Why?
Transplantation, Homologous
2
2013
415
0.040
 Why?
Colonic Neoplasms
1
2002
244
0.040
 Why?
Age Factors
2
2021
3278
0.040
 Why?
Vinblastine
1
2019
71
0.040
 Why?
Dacarbazine
1
2019
95
0.040
 Why?
Receptors, Antigen, T-Cell
1
2023
719
0.040
 Why?
Contrast Media
1
2022
470
0.040
 Why?
Vero Cells
2
2010
87
0.040
 Why?
Neoplasm Invasiveness
1
2021
508
0.040
 Why?
Medication Errors
1
2000
96
0.040
 Why?
Administration, Oral
2
2012
802
0.040
 Why?
Amino Acid Substitution
1
2019
309
0.040
 Why?
Antibodies, Viral
1
2023
652
0.040
 Why?
Intravitreal Injections
1
2018
60
0.040
 Why?
Cluster Analysis
2
2014
516
0.040
 Why?
Gamma Rays
1
2018
57
0.040
 Why?
Immunoglobulin G
1
2023
897
0.040
 Why?
Aging
1
2009
1917
0.040
 Why?
Injections, Intravenous
1
2018
201
0.040
 Why?
Seizures
1
2022
439
0.040
 Why?
Hospitals, Teaching
1
2018
115
0.040
 Why?
Chi-Square Distribution
2
2010
521
0.040
 Why?
Blotting, Western
2
2015
1231
0.040
 Why?
Anthracyclines
1
2018
41
0.040
 Why?
Brain Neoplasms
1
2007
1275
0.040
 Why?
Bleomycin
1
2019
248
0.030
 Why?
Tumor Suppressor Protein p53
1
2002
526
0.030
 Why?
Nursing Homes
1
2000
171
0.030
 Why?
Bendamustine Hydrochloride
1
2017
14
0.030
 Why?
United Kingdom
1
2018
319
0.030
 Why?
Plasma Exchange
1
2017
18
0.030
 Why?
Water Movements
1
2017
31
0.030
 Why?
Organoplatinum Compounds
1
2017
49
0.030
 Why?
Etoposide
2
2008
163
0.030
 Why?
Infant
3
2024
9790
0.030
 Why?
Rain
1
2017
45
0.030
 Why?
Immunoglobulin M
1
2018
287
0.030
 Why?
Cell Count
2
2009
325
0.030
 Why?
Animals
8
2015
37579
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2056
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
159
0.030
 Why?
Cell Separation
2
2010
317
0.030
 Why?
Neoplasms, Radiation-Induced
1
2017
98
0.030
 Why?
Green Fluorescent Proteins
2
2010
401
0.030
 Why?
Intensive Care Units
1
2022
869
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2011
757
0.030
 Why?
Neutropenia
1
2017
154
0.030
 Why?
Image Processing, Computer-Assisted
2
2011
771
0.030
 Why?
Registries
2
2017
2143
0.030
 Why?
Retina
1
2018
313
0.030
 Why?
Blood-Retinal Barrier
1
1996
12
0.030
 Why?
von Hippel-Lindau Disease
1
1996
12
0.030
 Why?
Particle Size
1
2017
404
0.030
 Why?
Chemotherapy, Adjuvant
1
2017
380
0.030
 Why?
Fundus Oculi
1
1996
86
0.030
 Why?
Acoustic Stimulation
1
2017
324
0.030
 Why?
Functional Neuroimaging
1
2015
60
0.030
 Why?
Extracellular Space
1
1996
129
0.030
 Why?
Cross-Sectional Studies
2
2017
5645
0.030
 Why?
Foot
1
2016
99
0.030
 Why?
Models, Theoretical
1
2018
580
0.030
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2015
62
0.030
 Why?
Adenine
1
2017
331
0.030
 Why?
Ankle Joint
1
2016
115
0.030
 Why?
France
1
2014
38
0.030
 Why?
Analysis of Variance
2
2009
1313
0.030
 Why?
Anxiety
1
2022
1076
0.030
 Why?
Clone Cells
1
2014
267
0.030
 Why?
Polyradiculoneuropathy
1
2013
4
0.030
 Why?
Ambulatory Care
1
2018
584
0.030
 Why?
Paraneoplastic Syndromes, Nervous System
1
2013
14
0.030
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
19
0.030
 Why?
Guillain-Barre Syndrome
1
2013
23
0.030
 Why?
Patient Reported Outcome Measures
1
2017
437
0.030
 Why?
Transfection
2
2006
936
0.030
 Why?
Sciatic Nerve
1
2013
63
0.030
 Why?
Immunoassay
1
2014
113
0.030
 Why?
Survival
1
2013
39
0.030
 Why?
Lymphatic Metastasis
1
2014
326
0.030
 Why?
In Vitro Techniques
1
2015
1093
0.020
 Why?
Tumor Cells, Cultured
1
2015
956
0.020
 Why?
Immunoenzyme Techniques
1
2013
207
0.020
 Why?
Medical Records
1
2013
182
0.020
 Why?
In Situ Hybridization
1
2013
319
0.020
 Why?
Vision, Binocular
1
1993
41
0.020
 Why?
Plasmacytoma
1
2012
19
0.020
 Why?
Psychomotor Performance
1
2015
329
0.020
 Why?
Neuropsychological Tests
1
2017
1089
0.020
 Why?
Brachytherapy
1
2013
131
0.020
 Why?
Transcription, Genetic
2
2011
1485
0.020
 Why?
Horner Syndrome
1
1992
6
0.020
 Why?
False Positive Reactions
1
2012
125
0.020
 Why?
Gastrointestinal Diseases
1
2014
206
0.020
 Why?
Research Design
1
2018
1104
0.020
 Why?
Hippocampus
2
2009
939
0.020
 Why?
Explosions
1
1991
14
0.020
 Why?
Costs and Cost Analysis
1
2012
219
0.020
 Why?
Farnesyltranstransferase
1
2011
21
0.020
 Why?
Food Labeling
1
1991
15
0.020
 Why?
Diagnostic Techniques, Ophthalmological
1
2011
50
0.020
 Why?
Tomography, Optical Coherence
1
2013
257
0.020
 Why?
Immunologic Techniques
1
2011
39
0.020
 Why?
Databases, Factual
1
2017
1441
0.020
 Why?
Interleukin-1beta
1
2013
386
0.020
 Why?
RNA Splicing Factors
1
2011
57
0.020
 Why?
Psychometrics
1
2015
734
0.020
 Why?
Blood Viscosity
1
2010
18
0.020
 Why?
Secondary Prevention
1
2012
240
0.020
 Why?
Iowa
1
2010
31
0.020
 Why?
Gastrointestinal Tract
1
2013
197
0.020
 Why?
Plasmapheresis
1
2010
24
0.020
 Why?
Phosphorylation
1
2015
1758
0.020
 Why?
Intelligence Tests
1
2010
63
0.020
 Why?
Prostaglandin Antagonists
1
1990
3
0.020
 Why?
Drug Therapy, Combination
2
2010
1038
0.020
 Why?
Cells, Cultured
2
2010
4199
0.020
 Why?
Silicon
1
2010
21
0.020
 Why?
Early Medical Intervention
1
2010
60
0.020
 Why?
Organ Size
1
2011
477
0.020
 Why?
Syk Kinase
1
2009
21
0.020
 Why?
Transplantation Chimera
1
2010
59
0.020
 Why?
Exons
1
2011
352
0.020
 Why?
Cannabinoid Receptor Antagonists
1
2009
2
0.020
 Why?
Frontal Lobe
1
2011
161
0.020
 Why?
Receptors, Cannabinoid
1
2009
15
0.020
 Why?
Accidents, Home
1
2009
33
0.020
 Why?
Poisson Distribution
1
2009
76
0.020
 Why?
Administration, Topical
1
1990
149
0.020
 Why?
Inflammation
1
2021
2891
0.020
 Why?
Boston
1
2009
91
0.020
 Why?
Equipment Failure Analysis
1
2010
131
0.020
 Why?
Tissue Distribution
1
2010
327
0.020
 Why?
Ophthalmic Solutions
1
1990
80
0.020
 Why?
Medulla Oblongata
1
2009
36
0.020
 Why?
Mice, SCID
1
2010
365
0.020
 Why?
Statistics as Topic
1
2010
298
0.020
 Why?
Periaqueductal Gray
1
2009
38
0.020
 Why?
Lacerations
1
2009
40
0.020
 Why?
Formaldehyde
1
2009
65
0.020
 Why?
Endophthalmitis
1
1989
45
0.020
 Why?
Tumor Burden
1
2010
310
0.020
 Why?
Alternative Splicing
1
2011
232
0.020
 Why?
Random Allocation
1
1990
363
0.020
 Why?
Vision Disorders
1
1991
167
0.020
 Why?
White Matter
1
2011
147
0.020
 Why?
Aminopyridines
1
2009
109
0.020
 Why?
Catheters, Indwelling
1
2009
90
0.020
 Why?
Macular Edema
1
1989
46
0.020
 Why?
Morpholines
1
2009
126
0.020
 Why?
Cataract
1
1992
223
0.020
 Why?
Prevalence
1
2016
2780
0.020
 Why?
Atrophy
1
2009
196
0.020
 Why?
Diagnosis, Differential
1
2013
1491
0.020
 Why?
Proto-Oncogene Proteins c-fos
1
2009
191
0.020
 Why?
Rats
2
2009
5594
0.020
 Why?
Intraoperative Complications
1
1990
147
0.020
 Why?
Bone Marrow
1
2010
301
0.020
 Why?
Diarrhea
1
2009
183
0.020
 Why?
Sulfur Hexafluoride
1
1988
2
0.020
 Why?
Factor Analysis, Statistical
1
2009
295
0.020
 Why?
Foreign Bodies
1
2009
107
0.020
 Why?
Mucositis
1
2008
20
0.020
 Why?
Prednisolone
1
1988
68
0.020
 Why?
Methods
1
1988
68
0.020
 Why?
Orbital Diseases
1
1988
32
0.020
 Why?
Chromatography, Liquid
1
2010
453
0.020
 Why?
Hot Temperature
1
1991
406
0.020
 Why?
Blindness
1
1988
49
0.020
 Why?
Air
1
1988
43
0.020
 Why?
Silicones
1
2008
26
0.020
 Why?
Equipment Design
1
2010
525
0.020
 Why?
Polyethylenes
1
2008
15
0.020
 Why?
Lymphocyte Subsets
1
2008
88
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2013
1241
0.020
 Why?
Vasculitis
1
1988
68
0.020
 Why?
Polytetrafluoroethylene
1
2008
25
0.020
 Why?
Purine-Nucleoside Phosphorylase
1
2007
6
0.020
 Why?
Membrane Cofactor Protein
1
2007
14
0.020
 Why?
Vitreous Hemorrhage
1
1987
9
0.020
 Why?
Sequence Deletion
1
2008
183
0.020
 Why?
Pneumonia
1
2014
656
0.020
 Why?
Up-Regulation
1
2011
856
0.020
 Why?
Leukocytes, Mononuclear
1
2010
572
0.020
 Why?
Timolol
1
1987
15
0.020
 Why?
Pilocarpine
1
1987
16
0.020
 Why?
Enzyme Inhibitors
1
2011
842
0.020
 Why?
Infant, Low Birth Weight
1
2008
145
0.020
 Why?
Ifosfamide
1
2007
38
0.020
 Why?
Infant, Newborn
2
2010
6257
0.020
 Why?
Gene Rearrangement
1
2008
148
0.020
 Why?
Prodrugs
1
2007
46
0.020
 Why?
Drug Therapy
1
2007
81
0.020
 Why?
Lymph Nodes
1
2010
500
0.020
 Why?
Xenograft Model Antitumor Assays
1
2010
903
0.020
 Why?
RNA-Binding Proteins
1
2011
447
0.020
 Why?
Tandem Mass Spectrometry
1
2010
568
0.020
 Why?
Carboplatin
1
2007
145
0.020
 Why?
Pain Measurement
1
2009
552
0.020
 Why?
Adrenal Cortex Hormones
1
2010
501
0.020
 Why?
Birth Weight
1
2010
511
0.020
 Why?
Trabeculectomy
1
1987
74
0.020
 Why?
Cerebral Hemorrhage
1
2007
116
0.020
 Why?
Prostheses and Implants
1
2008
143
0.020
 Why?
Cell Growth Processes
1
2006
52
0.020
 Why?
Neoplasm Metastasis
1
1989
674
0.020
 Why?
Legislation as Topic
1
1986
5
0.020
 Why?
Gestational Age
1
2010
952
0.020
 Why?
Injections
1
2007
191
0.020
 Why?
Enteral Nutrition
1
2008
201
0.020
 Why?
Immunocompetence
1
2006
44
0.020
 Why?
Mice
3
2010
18057
0.020
 Why?
Choroid Neoplasms
1
1986
8
0.020
 Why?
Epidemiologic Methods
1
2006
94
0.020
 Why?
Comorbidity
1
2011
1658
0.020
 Why?
Stress, Mechanical
1
1988
488
0.020
 Why?
Phenotype
1
2014
3172
0.010
 Why?
Attention Deficit Disorder with Hyperactivity
1
2010
435
0.010
 Why?
Rabbits
1
2007
754
0.010
 Why?
Gene Silencing
1
2006
197
0.010
 Why?
Imaging, Three-Dimensional
1
2009
566
0.010
 Why?
Tritium
1
2005
72
0.010
 Why?
Myelin Basic Protein
1
2005
44
0.010
 Why?
Thymidine
1
2005
60
0.010
 Why?
Nestin
1
2005
20
0.010
 Why?
Bromodeoxyuridine
1
2005
80
0.010
 Why?
Intermediate Filament Proteins
1
2005
58
0.010
 Why?
Pregnancy
2
2010
7035
0.010
 Why?
Glial Fibrillary Acidic Protein
1
2005
112
0.010
 Why?
Accidents, Traffic
1
1986
190
0.010
 Why?
RNA Interference
1
2006
468
0.010
 Why?
Transcriptional Activation
1
2006
377
0.010
 Why?
Genome-Wide Association Study
1
2011
1403
0.010
 Why?
Embryo, Mammalian
1
2005
234
0.010
 Why?
Software
1
2009
676
0.010
 Why?
Adenoviridae Infections
3
1958
19
0.010
 Why?
Microtubule-Associated Proteins
1
2005
198
0.010
 Why?
Infant, Premature
1
2008
598
0.010
 Why?
Cannabis
1
2011
510
0.010
 Why?
Biocompatible Materials
1
2008
428
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
985
0.010
 Why?
Length of Stay
1
2008
1259
0.010
 Why?
Mice, Transgenic
1
2007
2176
0.010
 Why?
Pediatrics
1
2010
1097
0.010
 Why?
Bed Rest
1
1981
15
0.010
 Why?
Antimetabolites, Antineoplastic
1
2002
93
0.010
 Why?
Recovery of Function
1
2006
680
0.010
 Why?
Joints
1
1982
106
0.010
 Why?
Immobilization
1
1981
46
0.010
 Why?
Bupivacaine
1
1981
38
0.010
 Why?
Colectomy
1
2002
105
0.010
 Why?
Nerve Tissue Proteins
1
2005
605
0.010
 Why?
Disease Models, Animal
1
2011
4407
0.010
 Why?
Oculomotor Muscles
1
1981
75
0.010
 Why?
Hypertension
1
2009
1251
0.010
 Why?
Suture Techniques
1
1981
128
0.010
 Why?
Adenoviridae
2
1958
200
0.010
 Why?
Light Coagulation
1
1980
10
0.010
 Why?
Movement
1
1982
290
0.010
 Why?
Gene Expression
1
2005
1490
0.010
 Why?
HeLa Cells
2
1958
639
0.010
 Why?
Rats, Sprague-Dawley
1
2005
2522
0.010
 Why?
Preoperative Care
1
1981
372
0.010
 Why?
Emergency Service, Hospital
1
2009
2190
0.010
 Why?
Diabetic Retinopathy
1
1980
201
0.010
 Why?
RNA, Messenger
1
2005
2822
0.010
 Why?
Cryotherapy
1
1996
18
0.010
 Why?
Laser Coagulation
1
1996
71
0.010
 Why?
Mice, Inbred C57BL
1
2005
5895
0.010
 Why?
Diabetes Mellitus
1
1982
1072
0.010
 Why?
Polyarteritis Nodosa
1
1988
11
0.000
 Why?
Virus Diseases
2
1956
215
0.000
 Why?
Kidney Failure, Chronic
1
1988
599
0.000
 Why?
Hand
1
1982
163
0.000
 Why?
Adenovirus Vaccines
1
1958
2
0.000
 Why?
Models, Biological
1
1986
1822
0.000
 Why?
Neutralization Tests
1
1956
81
0.000
 Why?
Antibody Formation
1
1956
297
0.000
 Why?
Viruses
1
1956
163
0.000
 Why?
Cell Culture Techniques
1
1956
368
0.000
 Why?
Johnston's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (717) concept(s)
_
Co-Authors Expand Description
See all (3) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)